Penetrium Bioscience tests new combination cancer treatment with Merck’s Keytruda
South Korea's Penetrium Bioscience said Wednesday that the company would start a clinical test combining its investigational cancer drug Penetrium with Merck's immunotherapy Keytruda.
Original Source
Read the full article at Upi →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.